Réaction #72027

ord-5d0eaec761644774b427ea0d3fda83b0

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    Concentrationconcentration under reduced pressure
  2. 2
    workup.DISSOLUTIONthe residue was dissolved in NMP (0.5 mL)
  3. 3
    workup.STIRRINGthe mixture was stirred
  4. 4
    Autrea microwave irradiation reactor at 150° C. for 10 minutes
  5. 5
    Extractionfollowed by extraction with ethyl acetate
  6. 6
    workup.ADDITIONSodium chloride was added to the aqueous layer
  7. 7
    Séchagedried over anhydrous sodium sulfate
  8. 8
    Concentrationconcentration under reduced pressure
  9. 9
    Autrethe residue was purified by silica gel column chromatography (elution solvent: dichloromethane/methanol=40/1, 20/1, 10/1)

Mode opératoire

tert-Butyl cis(±)-4-{[(4-chloro-5-ethyl-1H-imidazol-2-yl)carbonyl]amino}-3-methoxypiperidine-1-carboxylate obtained by the method described in Example (1g) (25 mg, 0.06 mmol) was dissolved in methanol (3 mL). A 4 N hydrochloric acid/ethyl acetate solution (2 mL) was added, and the mixture was stirred at room temperature for one hour. Following concentration under reduced pressure, the residue was dissolved in NMP (0.5 mL). Triethylamine (9.81 mg, 0.1 mmol) and methyl 6-bromo-pyridine-2-carboxylate (13.96 mg, 0.06 mmol) were added, and the mixture was stirred using a microwave irradiation reactor at 150° C. for 10 minutes. Water was added to the reaction solution, followed by extraction with ethyl acetate. Sodium chloride was added to the aqueous layer, followed by reextraction with ethyl acetate four times. The organic layers were combined and dried over anhydrous sodium sulfate. Following concentration under reduced pressure, the residue was purified by silica gel column chromatography (elution solvent: dichloromethane/methanol=40/1, 20/1, 10/1) to obtain 30.6 mg of the title compound.

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US08536197B2uspto-grants-2013_09